7th April 2017
- 0 comments
7 April
The GM&C Life Sciences Fund, managed by Catapult Ventures, has led a £4m investment in Proveca, a European paediatric speciality pharmaceutical company. The investment will fund the commercial launch of Sialanar™ and the development and commercialisation of its paediatric product portfolio.
...Register / Login now to read full story
In order to read the full story we need you to be registered with us, please click the links below to login or register.
Back to Homepage